Comparison of cutaneous tolerance and efficacy of calcitriol 3 μg g -1 ointment and tacrolimus 0.3 mg g-1 ointment in chronic plaque psoriasis involving facial or genitofemoral areas: A double-blind, randomized controlled trial

British Journal of Dermatology

Volumn 157, Issue 5, 2007, Pages 1005-1012

  Liao, Y H ^a   Chiu, H C ^a   Tseng, Y S ^a   Tsai, T F ^a  

^a NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

Author keywords

Calcitriol; Chronic plaque psoriasis; Sensitive areas; Tacrolimus

Indexed keywords

CALCITRIOL; TACROLIMUS;

ABNORMAL SENSATION; ACNE; ADULT; AGED; ARTICLE; BURNING SENSATION; CLINICAL ARTICLE; CLINICAL TRIAL; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG TOLERABILITY; EDEMA; ERYTHEMA; FACE; FEMALE; FOLLICULITIS; HOT SENSATION; HUMAN; MALE; PRIORITY JOURNAL; PSORIASIS VULGARIS; RANDOMIZED CONTROLLED TRIAL; SENSITIVITY ANALYSIS; SIDE EFFECT; STATISTICAL SIGNIFICANCE;

ADMINISTRATION, CUTANEOUS; ADULT; AGED; CALCITRIOL; DERMATOLOGIC AGENTS; DOUBLE-BLIND METHOD; FACIAL DERMATOSES; FEMALE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; MALE; MIDDLE AGED; OINTMENTS; PSORIASIS; TACROLIMUS; TREATMENT OUTCOME; VITAMINS;

EID: 35348855190     PISSN: 00070963     EISSN: 13652133     Source Type: Journal    
DOI: 10.1111/j.1365-2133.2007.08201.x     Document Type: Article

References (23)

1. Koo J. Population-based epidemiologic study of psoriasis with emphasis on quality of life assessment. Dermatol Clin 1996 14:485 96.
2. Farber EM, Nall ML. The natural history of psoriasis in 5,600 patients. Dermatologica 1974 148:1 18.
3. Harrison PV, Walker GB. Facial psoriasis. Clin Exp Dermatol 1985 10:41 4.
4. Young Park J, Hyun Rim J, Beom Choe Y, Il Youn J. Facial psoriasis: comparison of patients with and without facial involvement. J Am Acad Dermatol 2004 50:582 4.
5. Millis CM, Marks R. Side effects of topical glucocorticoids. Curr Probl Dermatol 1993 21:122 31.
6. Kienbaum S, Lehmann P, Ruzicka T. Topical calcipotriol in the treatment of intertriginous psoriasis. Br J Dermatol 1996 135:647 50.
7. Freeman AK, Linowski GJ, Brady C et al. Tacrolimus ointment for the treatment of psoriasis on the face and intertriginous areas. J Am Acad Dermatol 2003 48:564 8.
8. -1 ointment on chronic plaque psoriasis localized in facial, hairline, retroauricular or flexural areas. Br J Dermatol 2003 148:326 33.
9. Yamamoto T, Nishioka K. Topical tacrolimus: an effective therapy for facial psoriasis. Eur J Dermatol 2003 13:471 3.
10. Gribetz C, Ling M, Lebwohl M et al. Pimecrolimus cream 1% in the treatment of intertriginous psoriasis: a double-blind, randomized study. J Am Acad Dermatol 2004 51:731 8.
11. Lebwohl M, Freeman AK, Chapman MS et al. Tacrolimus ointment is effective for facial and intertriginous psoriasis. J Am Acad Dermatol 2004 51:723 30.
12. Rallis E, Nasiopoulou A, Kouskoukis C et al. Successful treatment of genital and facial psoriasis with tacrolimus ointment 0.1%. Drugs Exp Clin Res 2005 31:141 5.
13. Martin Ezquerra G, Sanchez Regana M, Herrera Acosta E, Umbert Millet P. Topical tacrolimus for the treatment of psoriasis on the face, genitalia, intertriginous areas and corporal plaques. J Drugs Dermatol 2006 5:334 6.
14. Kreuter A, Sommer A, Hyun J et al. 1% pimecrolimus, 0.005% calcipotriol, and 0.1% betamethasone in the treatment of intertriginous psoriasis: a double-blind, randomized controlled study. Arch Dermatol 2006 142:1138 43.
15. Ashcroft DM, Po AL, Williams HC et al. Systemic review of comparative efficacy and tolerability of calcipotriol in treating chronic plaque psoriasis. BMJ 2000 320:963 7.
16. -1 ointment. Br J Dermatol 2001 144 (Suppl. 58 17 19.
17. Soter NA, Fleischer AB Jr., Webster GF et al. Tacrolimus ointment for the treatment of atopic dermatitis in adult patients: Part II, safety. J Am Acad Dermatol 2001 44:S39 46.
18. Serup J. Skin tolerability of calcipotriol. In:Vitamin D in Dermatology (Kragsalle K, ed. New York:Marcel Dekker, Inc., 2000 225 37.
19. -1 ointment in the treatment of mild-to-moderate psoriasis: results from an open-label study. J Eur Acad Dermatol Venereol 2005 19 (Suppl. 3 11 13.
20. -1 ointment in combination with ultraviolet B phototherapy for the treatment of plaque psoriasis: results of a comparative study. Br J Dermatol 2001 144:495 9.
21. Hofmann UB, Eggert AA, Brocker EB, Goebeler M. Calcitriol vs. dithranol in combination with narrow-band ultraviolet B (311 nm) in psoriasis. Br J Dermatol 2003 148:779 83.
22. Niwa Y, Terashima T, Sumi H. Topical application of the immunosuppressant tacrolimus accelerates carcinogenesis in mouse skin. Br J Dermatol 2003 149:960 7.
23. Berger TG, Duvic M, van Voorhees AS, Frieden IJ. The use of topical calcineurin inhibitors in dermatology: safety concerns. J Am Acad Dermatol 2006 54:818 23.